Get started
Author

Gábor Vogt

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
2023 · Arshad M Khanani, Sunil S Patel, et al. · The Lancet · 392
PDF
TENAYA and LUCERNE
2024 · Arshad M. Khanani, Aachal Kotecha, et al. · Ophthalmology · 251
Faricimab Treat-and-Extend for Diabetic Macular Edema
2023 · Tien Y. Wong, Zdenka Haskova, et al. · Ophthalmology · 192
PDF
Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration
2020 · Se Joon Woo, Miroslav Veith, et al. · JAMA Ophthalmology · 86
PDF
A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration
2023 · Timothy L. Jackson, Jason Slakter, et al. · Ophthalmology · 57
PDF
Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes
2021 · Neil M Bressler, Miroslav Veith, et al. · British Journal of Ophthalmology · 49
PDF
Functional aspects of drusen regression in age-related macular degeneration
2009 · F B Sallo, E Rechtman, et al. · British Journal of Ophthalmology · 37
Population‐based case‐control study of isolated congenital cataract
2005 · Gábor Vogt, Erzsébet Puhó, et al. · Birth Defects Research Part A Clinical and Molecular Teratology · 31
A Population-Based Case-Control Study of Isolated Ocular Coloboma
2005 · Gábor Vogt, Erzsébet Puhó, et al. · Ophthalmic Epidemiology · 28
Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study
2020 · Francesco Oddone, Lucia Tanga, et al. · Advances in Therapy · 26
PDF
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial
2023 · Masahiko Shimura, Shigehiko Kitano, et al. · Japanese Journal of Ophthalmology · 23
PDF
Primary Prevention of Congenital Abnormalities Due to High Fever Related Maternal Diseases by Antifever Therapy and Folic Acid Supplementation
2007 · Andrew E. Czeizel, Nandor Acs, et al. · Current Women s Health Reviews · 22
Birth Characteristics of Different Ocular Congenital Abnormalities in Hungary
2006 · Gábor Vogt, Melinda Szunyogh, et al. · Ophthalmic Epidemiology · 21
A Population-based Case–control Study of Isolated Anophthalmia and Microphthalmia
2005 · Gábor Vogt, Erzsébet Puhó, et al. · European Journal of Epidemiology · 15
A population‐based case‐control study of isolated primary congenital glaucoma
2006 · Gábor Vogt, Erzsébet Horváth‐Puhó, et al. · American Journal of Medical Genetics Part A · 14
Maternal Demographic and Socioeconomic Characteristics of Live-Born Infants With Isolated Ocular Congenital Abnormalities
2008 · Erzsébet H. Puhó, Gábor Vogt, et al. · Ophthalmic Epidemiology · 12
Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy
2025 · Won Ki Lee, Tien Y. Wong, et al. · JAMA Ophthalmology · 10
Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment
2022 · Francesco Oddone, James Kirwan, et al. · Advances in Therapy · 8
PDF
Microcephaly with normal intelligence, and chorioretinopathy
1999 · Ghada M.H. Abdel-Salam, Gábor Vogt, et al. · Ophthalmic Genetics · 8
[A population-based case-control study of isolated congenital cataract].
2006 · Gábor Vogt, Erzsébet Horváth-Puhó, et al. · PubMed · 7
Homozygous E387K (1159G>A) mutation of the CYP1B1 gene in a Roma boy affected with primary congenital glaucoma. Case report
2014 · Gábor Vogt, Ľudevit/Lajos Kádasi, et al. · Orvosi Hetilap · 4
Potential 20-Week Faricimab Dosing in Wet Age-Related Macular Degeneration
2026 · Aude Ambresin, Varun Chaudhary, et al. · Ophthalmology Retina · 3
PULSAR: Clinical Outcomes of Aflibercept 8 mg with Extended Dosing and 2 mg in Neovascular Age-Related Macular Degeneration in Subgroups Defined by Baseline Characteristics
2026 · Richard P. Gale, Anat Loewenstein, et al. · Ophthalmology Retina · 2
Correction to: Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study
2020 · Francesco Oddone, Lucia Tanga, et al. · Advances in Therapy · 2
PDF
Correction to: Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment
2022 · Francesco Oddone, James Kirwan, et al. · Advances in Therapy · 1
PDF
Works count: 29
Citation count: 1,301
H-index: 14
I10-index: 17
Year
Topic
Type